Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway

PURPOSE: Sarcopenia has been described as a new complication of type 2 diabetes mellitus (T2DM). T2DM and sarcopenia impact each other, resulting in a variety of adverse outcomes such as frailty, disability, poor quality of life and increased mortality. Sodium butyrate (NaB) is reported to play a pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yuan, Li, Yulin, Han, Wenqiang, Jia, Xu, Zhu, Ping, Wei, Bin, Cong, Xiaoyan, Wang, Zhihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888475/
https://www.ncbi.nlm.nih.gov/pubmed/36733489
http://dx.doi.org/10.2147/JIR.S392350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888475/
https://www.ncbi.nlm.nih.gov/pubmed/36733489
http://dx.doi.org/10.2147/JIR.S392350

Ejemplares similares